CHARLES SCHWAB INVESTMENT MANAGEMENT INC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$5,914
-83.0%
35,7320.0%0.00%
Q1 2023$34,874
-6.2%
35,7320.0%0.00%
Q4 2022$37,161
-11.5%
35,7320.0%0.00%
Q3 2022$42,000
-37.3%
35,7320.0%0.00%
Q2 2022$67,000
-38.5%
35,7320.0%0.00%
Q1 2022$109,000
-19.9%
35,7320.0%0.00%
Q4 2021$136,000
+34.7%
35,732
+83.8%
0.00%
Q3 2021$101,000
+34.7%
19,4370.0%0.00%
Q2 2021$75,000
-78.8%
19,437
-85.8%
0.00%
Q1 2021$353,000
+10.3%
137,233
+7.4%
0.00%
Q4 2020$320,000
+29.0%
127,819
+7.1%
0.00%
Q3 2020$248,000
-36.7%
119,348
-5.6%
0.00%
Q2 2020$392,000
+46.8%
126,381
+7.9%
0.00%
Q1 2020$267,000
-36.4%
117,103
+0.9%
0.00%
Q4 2019$420,000
+6.1%
116,0180.0%0.00%
Q3 2019$396,000
-12.8%
116,018
+20.1%
0.00%
Q2 2019$454,000
-40.4%
96,581
-57.5%
0.00%
Q1 2019$762,000
+33.7%
227,425
+6.1%
0.00%
Q4 2018$570,000
-52.5%
214,2570.0%0.00%
-100.0%
Q3 2018$1,200,000
+10.4%
214,2570.0%0.00%0.0%
Q2 2018$1,087,000
+123.2%
214,257
+200.1%
0.00%
Q1 2018$487,000
+12.0%
71,400
+24.0%
0.00%
Q4 2017$435,000
+31.0%
57,6000.0%0.00%
Q3 2017$332,000
+13.7%
57,6000.0%0.00%
Q2 2017$292,00057,6000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders